Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 April 2006, Vol. 107, No. 8, pp. 3258-3264.
Prepublished online as a Blood First Edition Paper on December 22, 2005; DOI 10.1182/blood-2005-11-4374.


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2005-11-4374v1
107/8/3258    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Belyakov, I. M.
Right arrow Articles by Berzofsky, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Belyakov, I. M.
Right arrow Articles by Berzofsky, J. A.
Related Collections
Right arrow Immunobiology
Right arrow Immunotherapy
Right arrow Free Research Articles
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

IMMUNOBIOLOGY

Impact of vaccine-induced mucosal high-avidity CD8+CTLs in delay of AIDS viral dissemination from mucosa

Igor M. Belyakov, Vladimir A. Kuznetsov, Brian Kelsall, Dennis Klinman, Marcin Moniuszko, Michael Lemon, Phillip D. Markham, Ranajit Pal, John D. Clements, Mark G. Lewis, Warren Strober, Genoveffa Franchini, and Jay A. Berzofsky

From the Vaccine Branch, National Cancer Institute (NCI) and Laboratory of Clinical Investigation, National Institute of Allergy and Infectious Disease (NIAID), National Institutes of Health (NIH), Bethesda, MD; Division of Information and Mathematical Sciences, Genome Institute of Singapore, Singapore; Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD; Advanced BioScience Laboratories, Kensington, MD; Department of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, LA; and Southern Research Institute, Frederick, MD.

Natural HIV transmission occurs through mucosa, but it is debated whether mucosal cytotoxic T lymphocytes (CTLs) can prevent or reduce dissemination from the initial mucosal site to the systemic circulation. Also, the role of CTL avidity in mucosal AIDS viral transmission is unknown. To address these questions, we used delay in acute-phase peak viremia after intrarectal challenge as an indicator of systemic dissemination. We found that a peptide-prime/poxviral boost vaccine inducing high levels of high-avidity mucosal CTLs can have an impact on dissemination of intrarectally administered pathogenic SHIV-ku2 in macaques and that such protection correlates better with mucosal than with systemic CTLs and particularly with levels of high-avidity mucosal CTLs.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article in Blood Online:

Keeping the barbarian at the gate
George K. Lewis
Blood 2006 107: 3020. [Full Text] [PDF]



This article has been cited by other articles:


Home page
Int ImmunolHome page
I. M. Belyakov, S. Kozlowski, M. Mage, J. D. Ahlers, L. F. Boyd, D. H. Margulies, and J. A. Berzofsky
Role of {alpha}3 domain of class I MHC molecules in the activation of high- and low-avidity CD8+ CTLs
Int. Immunol., December 1, 2007; 19(12): 1413 - 1420.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I. M. Belyakov, D. Isakov, Q. Zhu, A. Dzutsev, and J. A. Berzofsky
A Novel Functional CTL Avidity/Activity Compartmentalization to the Site of Mucosal Immunization Contributes to Protection of Macaques against Simian/Human Immunodeficiency Viral Depletion of Mucosal CD4+ T Cells
J. Immunol., June 1, 2007; 178(11): 7211 - 7221.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. C. G. Marcondes, T. H. Burdo, S. Sopper, S. Huitron-Resendiz, C. Lanigan, D. Watry, C. Flynn, M. Zandonatti, and H. S. Fox
Enrichment and Persistence of Virus-Specific CTL in the Brain of Simian Immunodeficiency Virus-Infected Monkeys Is Associated with a Unique Cytokine Environment
J. Immunol., May 1, 2007; 178(9): 5812 - 5819.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
A. H. Dzutsev, I. M. Belyakov, D. V. Isakov, D. H. Margulies, and J. A. Berzofsky
Avidity of CD8 T cells sharpens immunodominance
Int. Immunol., April 1, 2007; 19(4): 497 - 507.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I. M. Belyakov, D. Isakov, Q. Zhu, A. Dzutsev, D. Klinman, and J. A. Berzofsky
Enhancement of CD8+ T Cell Immunity in the Lung by CpG Oligodeoxynucleotides Increases Protective Efficacy of a Modified Vaccinia Ankara Vaccine against Lethal Poxvirus Infection Even in a CD4-Deficient Host
J. Immunol., November 1, 2006; 177(9): 6336 - 6343.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2006 by American Society of Hematology         Online ISSN: 1528-0020